Clay B Siegall - Net Worth and Insider Trading

Clay B Siegall Net Worth

The estimated net worth of Clay B Siegall is at least $160 Million dollars as of 2024-03-19. Clay B Siegall is the President & CEO of Seagen Inc and owns about 666,060 shares of Seagen Inc (SGEN) stock worth over $152 Million. Clay B Siegall is the President and CEO of Immunome Inc and owns about 319,636 shares of Immunome Inc (IMNM) stock worth over $7 Million. Clay B Siegall is also the Director of Ultragenyx Pharmaceutical Inc and owns about 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $118,703. Besides these, Clay B Siegall also holds Alder BioPharmaceuticals Inc (ALDR) . Details can be seen in Clay B Siegall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Clay B Siegall has not made any transactions after 2023-10-02 and currently still holds the listed stock(s).

Transaction Summary of Clay B Siegall

To

Clay B Siegall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Clay B Siegall owns 6 companies in total, including Seagen Inc () , Ultragenyx Pharmaceutical Inc () , and Alder BioPharmaceuticals Inc () among others .

Click here to see the complete history of Clay B Siegall’s form 4 insider trades.

Insider Ownership Summary of Clay B Siegall

Ticker Comapny Transaction Date Type of Owner
Seagen Inc 2022-05-12 director & President and CEO
Ultragenyx Pharmaceutical Inc 2020-08-10 director
Alder BioPharmaceuticals Inc 2019-10-22 director
Synlogic Inc 2015-09-30 director
Nurix Therapeutics Inc 2021-05-28 director
Immunome Inc 2023-10-02 director & President and CEO

Clay B Siegall Latest Holdings Summary

Clay B Siegall currently owns a total of 4 stocks. Among these stocks, Clay B Siegall owns 666,060 shares of Seagen Inc (SGEN) as of May 12, 2022, with a value of $152 Million and a weighting of 95.45%. Clay B Siegall owns 319,636 shares of Immunome Inc (IMNM) as of October 2, 2023, with a value of $7 Million and a weighting of 4.43%. Clay B Siegall also owns 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) as of August 10, 2020, with a value of $118,703 and a weighting of 0.07%. The other 1 stocks Alder BioPharmaceuticals Inc (ALDR) have a combined weighting of 0.05% among all his current holdings.

Latest Holdings of Clay B Siegall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2022-05-12 666,060 228.74 152,354,564
IMNM Immunome Inc 2023-10-02 319,636 22.10 7,063,956
RARE Ultragenyx Pharmaceutical Inc 2020-08-10 2,550 46.55 118,703
ALDR Alder BioPharmaceuticals Inc 2015-05-18 4,444 18.88 83,903

Holding Weightings of Clay B Siegall


Clay B Siegall Form 4 Trading Tracker

According to the SEC Form 4 filings, Clay B Siegall has made a total of 42 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 42 sells. The most-recent trade in Seagen Inc is the sale of 17,043 shares on May 12, 2022, which brought Clay B Siegall around $2 Million.

According to the SEC Form 4 filings, Clay B Siegall has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 169,204 shares on October 2, 2023, which cost Clay B Siegall around $999,996.

According to the SEC Form 4 filings, Clay B Siegall has made a total of 1 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 34,750 shares on August 10, 2020, which brought Clay B Siegall around $3 Million.

More details on Clay B Siegall's insider transactions can be found in the Insider Trading History of Clay B Siegall table.

Insider Trading History of Clay B Siegall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Clay B Siegall Trading Performance

GuruFocus tracks the stock performance after each of Clay B Siegall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clay B Siegall is 34.27%. GuruFocus also compares Clay B Siegall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clay B Siegall within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Clay B Siegall's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Clay B Siegall

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 6.22 34.27
Relative Return to S&P 500(%) 5.53 23.67

Clay B Siegall Ownership Network

Ownership Network List of Clay B Siegall

No Data

Ownership Network Relation of Clay B Siegall


Clay B Siegall Owned Company Details

What does Seagen Inc do?

Who are the key executives at Seagen Inc?

Clay B Siegall is the director & President and CEO of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .

Seagen Inc () Insider Trades Summary

Over the past 18 months, Clay B Siegall made no insider transaction in Seagen Inc (). Other recent insider transactions involving Seagen Inc () include a net sale of 36,447 shares made by Jean I Liu , a net sale of 56,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 423,479 shares of Seagen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 423,479 shares.

Seagen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seagen Inc Insider Transactions

No Available Data

Clay B Siegall Mailing Address

Above is the net worth, insider trading, and ownership report for Clay B Siegall. You might contact Clay B Siegall via mailing address: 21823 30th Dr Se, Bothell Wa 98021.

Discussions on Clay B Siegall

No discussions yet.